Pondering vexing issues in infection prevention and control
Showing posts with label duodenoscope. Show all posts
Showing posts with label duodenoscope. Show all posts
Monday, March 7, 2016
Endoscope Reprocessing Practices Survey
The International Society for Chemotherapy (ISC) Infection Prevention & Control Working Group has developed a survey on current endoscope reprocessing practices and they need your help. The working group leadership includes Andreas Voss, Andreas Widmer, Ermira Tartari and Peter Collignon. With the survey they are particularly interested in comparing practices across the globe.
Please consider taking a few minutes and completing the survey for them.
Friday, February 20, 2015
Drug resistant bacteria versus advanced medical technology: No contest
The duodenoscope implicated now in several deadly outbreaks of carbapenem-resistant Enterobacteriaceae (CRE) is an otherwise terrific device for management of biliary or pancreatic duct disorders. Unfortunately, the same features that allow the scope to guide fine instruments into miniscule spaces also provide sanctuary for bacterial pathogens, protecting them from all standard approaches to disinfection. To quote yesterday’s FDA safety communication:
“…reports associate multidrug-resistant bacterial infections in patients who have undergone ERCP with reprocessed duodenoscopes, even when manufacturer reprocessing instructions are followed correctly. Meticulously cleaning duodenoscopes prior to high-level disinfection should reduce the risk of transmitting infection, but may not entirely eliminate it.”
Translation: you pays your money and you takes your chances.
There aren’t any great options for further reducing the (albeit small) risk for infection transmission from these devices. Some hospitals that have experienced outbreaks have switched to ethylene oxide gas, which is time-consuming and may still fail if organic debris remains in the tiny spaces that are so difficult to clean mechanically. Microbiological surveillance (culturing scopes after disinfection) is time-consuming, costly, and has unknown sensitivity for detection of transmission risk.
This problem is just one example of the limitations that antimicrobial resistance and infection control practice place on advanced healthcare delivery. Each year we see advances in our ability to provide life-saving care—but each of these advances can be easily circumvented by a simple lapse in infection control practice, or an untreatable bacterial pathogen.
As for this particular device, there must be a safer approach that doesn’t sacrifice utility. In a world where you can buy a robot hat-backpack that feeds you tomatoes while you jog, there must be a way to design a duodenoscope that can be effectively cleaned.
Subscribe to:
Posts (Atom)
OSHA! OSHA! OSHA!
In many parts of the country, as rates of COVID-19 are declining and vaccination coverage is increasing (albeit with substantial variati...
-
Back on clinical service again and having more thoughts on poor hospital design. Last month I wondered why there were no stethoscope wipe...
-
Those that follow me on twitter or the blog have probably noticed my recent focus on trying to understand the emergence of compulsory influe...
-
REUTERS/Athit Perawongmetha With the assistance of a great supply management team, we have been able to outfit all of our clinical staff wit...

